Lisanti Capital Growth, LLC Dyne Therapeutics, Inc. Transaction History
Lisanti Capital Growth, LLC
- $371 Million
- Q4 2024
A detailed history of Lisanti Capital Growth, LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Lisanti Capital Growth, LLC holds 57,755 shares of DYN stock, worth $661,294. This represents 0.37% of its overall portfolio holdings.
Number of Shares
57,755
Previous 17,310
233.65%
Holding current value
$661,294
Previous $621,000
119.0%
% of portfolio
0.37%
Previous 0.18%
Shares
4 transactions
Others Institutions Holding DYN
# of Institutions
212Shares Held
103MCall Options Held
135KPut Options Held
435K-
Atlas Venture Life Science Advisors, LLC8.02MShares$91.8 Million31.16% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$84.6 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.38MShares$84.5 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.7MShares$76.8 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.38MShares$73.1 Million2.43% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $593M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...